444 related articles for article (PubMed ID: 27600182)
21. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
22. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism.
Magill SB; Raff H; Shaker JL; Brickner RC; Knechtges TE; Kehoe ME; Findling JW
J Clin Endocrinol Metab; 2001 Mar; 86(3):1066-71. PubMed ID: 11238487
[TBL] [Abstract][Full Text] [Related]
23. Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration.
Baron S; Amar L; Faucon AL; Blanchard A; Baffalie L; Faucard C; Travers S; Pagny JY; Azizi M; Houillier P
J Hypertens; 2018 Jul; 36(7):1592-1601. PubMed ID: 29677048
[TBL] [Abstract][Full Text] [Related]
24. Analysis of postoperative biochemical values and clinical outcomes after adrenalectomy for primary aldosteronism.
Swearingen AJ; Kahramangil B; Monteiro R; Krishnamurthy V; Jin J; Shin J; Siperstein A; Berber E
Surgery; 2018 Apr; 163(4):807-810. PubMed ID: 29249599
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism.
Willenberg HS; Vonend O; Schott M; Gao X; Blondin D; Saleh A; Rump LC; Scherbaum WA
Horm Metab Res; 2012 Jun; 44(7):527-32. PubMed ID: 22689209
[TBL] [Abstract][Full Text] [Related]
26. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing.
Reznik Y; Amar L; Tabarin A
Ann Endocrinol (Paris); 2016 Jul; 77(3):202-7. PubMed ID: 27318644
[TBL] [Abstract][Full Text] [Related]
27. Basal contralateral aldosterone suppression is rare in lateralized primary aldosteronism.
Desrochers MJ; St-Jean M; El Ghorayeb N; Bourdeau I; So B; Therasse É; Kline G; Lacroix A
Eur J Endocrinol; 2020 Oct; 183(4):399-409. PubMed ID: 32698132
[TBL] [Abstract][Full Text] [Related]
28. Outcome of surgical treatment of primary aldosteronism.
Citton M; Viel G; Rossi GP; Mantero F; Nitti D; Iacobone M
Langenbecks Arch Surg; 2015 Apr; 400(3):325-31. PubMed ID: 25567077
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes following unilateral adrenalectomy in patients with primary aldosteronism.
Hannon MJ; Sze WC; Carpenter R; Parvanta L; Matson M; Sahdev A; Druce MR; Berney DM; Waterhouse M; Akker SA; Drake WM
QJM; 2017 May; 110(5):277-281. PubMed ID: 28180906
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Adrenal Vein Sampling Use and Outcomes in Patients With Primary Aldosteronism.
Yeung A; Friedmann P; In H; Bloomgarden N; McAuliffe JC; Libutti SK; Laird AM
J Surg Res; 2020 Dec; 256():673-679. PubMed ID: 32827833
[TBL] [Abstract][Full Text] [Related]
31. Diagnostics of primary aldosteronism: is obligatory use of confirmatory tests justified?
Myśliwiec J; Zukowski Ł; Grodzka A; Piłaszewicz A; Dragowski S; Górska M
J Renin Angiotensin Aldosterone Syst; 2012 Sep; 13(3):367-71. PubMed ID: 22406967
[TBL] [Abstract][Full Text] [Related]
32. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
33. Subtype Identification of Surgically Curable Primary Aldosteronism During Treatment With Mineralocorticoid Receptor Blockade.
Pintus G; Seccia TM; Amar L; Azizi M; Riester A; Reincke M; Widimský J; Naruse M; Kocjan T; Negro A; Kline G; Tanabe A; Satoh F; Rump LC; Vonend O; Fuller PJ; Yang J; Chee NYN; Magill SB; Shafigullina Z; Quinkler M; Oliveras A; Lee BC; Chang CC; Wu VC; Krátká Z; Battistel M; Bagordo D; Caroccia B; Ceolotto G; Rossitto G; Rossi GP
Hypertension; 2024 Jun; 81(6):1391-1399. PubMed ID: 38525605
[TBL] [Abstract][Full Text] [Related]
34. Adrenal Vein Sampling for Primary Aldosteronism: A 2-Week Protocol for Withdrawal of Renin-Stimulating Antihypertensives.
Ching KC; Cohen DL; Fraker DL; Trerotola SO
Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1367-1371. PubMed ID: 28378050
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Biochemical Conditions Allowing Bypass of Confirmatory Testing in The Workup of Primary Aldosteronism: A Retrospective Study in a French Hypertensive Population.
Vivien M; Deberles E; Morello R; Haddouche A; Guenet D; Reznik Y
Horm Metab Res; 2019 Mar; 51(3):172-177. PubMed ID: 30861563
[TBL] [Abstract][Full Text] [Related]
36. A marked proportional rise in IVC aldosterone following cosyntropin administration during AVS is a signal to the presence of adrenal hyperplasia in primary aldosteronism.
Kline GA; Pasieka JL; Harvey A; So B; Dias VC
J Hum Hypertens; 2014 May; 28(5):298-302. PubMed ID: 24284382
[TBL] [Abstract][Full Text] [Related]
37. Aldosterone Reduction Rate After Saline Infusion Test May Be a Novel Prediction in Patients With Primary Aldosteronism.
Nagano H; Kono T; Saiga A; Kubota Y; Fujimoto M; Felizola SJA; Ishiwata K; Tamura A; Higuchi S; Sakuma I; Hashimoto N; Suzuki S; Koide H; Takeshita N; Sakamoto S; Ban T; Yokote K; Nakamura Y; Ichikawa T; Uno T; Tanaka T
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31628466
[TBL] [Abstract][Full Text] [Related]
38. The aldosterone/renin ratio as a screening test for primary aldosteronism.
Rayner BL; Opie LH; Davidson JS
S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
[TBL] [Abstract][Full Text] [Related]
39. Is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy?
Zarnegar R; Bloom AI; Lee J; Kerlan RK; Wilson MW; Laberge JM; Gordon RL; Kebebew E; Clark OH; Duh QY
J Vasc Interv Radiol; 2008 Jan; 19(1):66-71. PubMed ID: 18192469
[TBL] [Abstract][Full Text] [Related]
40. Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
Tamura N; Watanabe E; Shirakawa R; Nakatani E; Yamada K; Hatakeyama H; Torii-Hanakita M; Kyo C; Kosugi R; Ogawa T; Kotani M; Usui T; Inoue T
PLoS One; 2021; 16(7):e0253807. PubMed ID: 34242264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
